Dhampur Bio Organics Ltd
Food Beverages & Tobacco | Small Cap
Dhampur Bio Organics Ltd, operating in the FMCG sector, shows a mixed financial performance. The company demonstrates strong solvency and profitability, indicating a solid foundation in managing debt and generating profits. However, liquidity and efficiency ratios suggest potential challenges in meeting short-term obligations and utilizing assets effectively. While revenue and asset growth are positive, declines in operating profit, EPS, and net income growth raise concerns about long-term sustainability. The company's coverage ratios are average, reflecting an adequate but not outstanding ability to cover interest and dividend payments. Overall, Dhampur Bio Organics exhibits financial strengths in certain areas, but needs to address weaknesses to ensure sustained growth and stability.
Latest Report
View AllLatest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
- Valuation MetricsNeutral
- Market Metrics
- Stock Reports
- Stock News
- Growth Ratio4.80
- Financial Ratio2.80
- Profitability Ratio9.60
- Efficiency Ratio4.67
- Coverage Ratio6.00
- Solvency Ratio10.00
- Liquidity Ratio2.90
- Peer Assessment
- Management AssessmentBalanced
- Risk AssessmentBalanced
- 1 HourNeutral
- 2 HoursNeutral
- 4 HoursNeutral
- 1 DayNeutral
- 1 WeekNeutral
- 1 MonthNeutral
Dhampur Bio Organics Ltd, operating in the FMCG sector, shows a mixed financial performance. The company demonstrates strong solvency and profitability, indicating a solid foundation in managing debt and generating profits. However, liquidity and efficiency ratios suggest potential challenges in meeting short-term obligations and utilizing assets effectively. While revenue and asset growth are positive, declines in operating profit, EPS, and net income growth raise concerns about long-term sustainability. The company's coverage ratios are average, reflecting an adequate but not outstanding ability to cover interest and dividend payments. Overall, Dhampur Bio Organics exhibits financial strengths in certain areas, but needs to address weaknesses to ensure sustained growth and stability.
Latest Report
View AllLatest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
Overall Valuation Score
P/E RATIO (TTM)
N/A
Industry Median
11.94
Small Cap Median
11.94
P/E RATIO
53.71
P/B RATIO
0.82
Industry Median
0.99
Small Cap Median
0.99
P/S RATIO
0.42
Industry Median
0.60
Small Cap Median
0.60
Others
PEG RATIO
0.00
EV/EBITDA RATIO
6.88
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹118.71 as on Jun 15, 2026.
Unlock Live Chart
Please login to view interactive real-time technical charts powered by TradingView.
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
0.00
Today's Low
0.00
Today's High
Quarterly Report⬤21st Jan 26
Quarterly Financial Results Q3 FY 2025–26
NEUTRAL SENTIMENT
Concall Report⬤29th Jul 25
Ql FY26 Result Conference Call
NEUTRAL SENTIMENT
The company's growth ratios present a mixed picture. While revenue and asset growth are positive, declines in operating profit, EPS, and net income growth raise concerns about long-term sustainability. The weighted average calculation underscores the need for the company to address these declines to ensure future growth prospects.
| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 53.96 | -22.59 | -0.11 | 13.27 | |
| Operating Profit Growth Rate | 12.02 | -31.71 | -3.57 | -2.96 | |
| Earnings Per Share (EPS) Growth | -58.18 | -68.43 | 71.49 | ||
| Asset Growth Rate | 28.95 | 3.85 | 11.36 | 3.67 | -3.17 |
| Net Income Growth Rate | 8.82 | -58.56 | -67.39 | 66.67 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
The company's financial ratios reveal an area of concern, with low adjusted EPS, cash EPS, book value per share, dividend per share, and high capital expenditures. The weighted average calculation further emphasizes these financial challenges, highlighting the need for strategic improvements in earnings, shareholder value, and capital management.
| Financial Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Adjusted Earnings Per Share (Adjusted EPS) | 15.3 | 16.82 | 5.45 | 2.42 | 3.79 |
| Cash Earnings Per Share (Cash EPS) | 20.15 | 23.03 | 14.39 | 10.45 | 12.73 |
| Book Value Per Share | 133.03 | 149.7 | 153.18 | 153.18 | 155.45 |
| Dividend Per Share (DPS) | 3.52 | 2.52 | 1.24 | 1.52 | |
| Capital Expenditures (CapEx) | 142.4 | 210.2 | 144 | 144.8 | 42.4 |
Adjusted Earnings Per Share (Adjusted EPS)
Cash Earnings Per Share (Cash EPS)
Book Value Per Share
Dividend Per Share (DPS)
Capital Expenditures (CapEx)
The company demonstrates strong profitability, reflecting its ability to generate profits from its operations and investments. The gross profit, ROCE, ROE, and net margin ratios are at healthy levels, indicating efficient management and effective utilization of capital. The weighted average calculation underscores the company's consistent strength in maintaining high profitability margins.
| Profitability Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Profit Margin | 9.72 | 6.81 | 4.88 | 4.35 | 3.41 |
| Return on Capital Employed (ROCE) | 11 | 10 | 5 | 4 | 5 |
| Return on Equity (ROE) | 11.62 | 11.23 | 4.55 | 1.48 | 2.44 |
| Return on Assets (ROA) | 9.15 | 9.87 | 6.05 | 5.63 | 5.64 |
| Operating Margin | 11.7 | 8.51 | 7.51 | 7.25 | 6.21 |
| Net Margin | 6.52 | 4.61 | 2.47 | 0.81 | 1.19 |
Gross Profit Margin
Return on Capital Employed (ROCE)
Return on Equity (ROE)
Return on Assets (ROA)
Operating Margin
Net Margin
The efficiency ratios present a mixed view of the company's operational management. While receivables turnover and receivable days indicate effective credit and collection policies, fixed asset, inventory, and capital turnover ratios suggest potential inefficiencies in asset utilization. The weighted average calculation underscores the need for the company to optimize its asset management practices to improve overall efficiency.
| Efficiency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Fixed Asset Turnover Ratio | 2.27 | 2.65 | 1.8 | 1.73 | 1.86 |
| Inventory Turnover Ratio | 1.59 | 2.39 | 1.86 | 1.64 | 1.93 |
| Receivables Turnover Ratio | 14.55 | 18.38 | 15.4 | 26.04 | 35.45 |
| Days Sales in Inventory Ratio | 229.56 | 152.72 | 196.24 | 222.56 | 189.12 |
| Receivable Days | 25.09 | 19.86 | 23.7 | 14.02 | 10.3 |
| Capital Turnover Ratio | 1.58 | 2.07 | 1.56 | 1.48 | 1.7 |
Fixed Asset Turnover Ratio
Inventory Turnover Ratio
Receivables Turnover Ratio
Days Sales in Inventory Ratio
Receivable Days
Capital Turnover Ratio
The company's coverage ratios are average, reflecting an adequate but not outstanding ability to cover interest and dividend payments. While the company can meet its interest and dividend obligations, there is room to improve these ratios for added financial security.
| Coverage Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Interest Coverage Ratio | 5.3 | 4.29 | 2.44 | 1.24 | 1.65 |
| Equity Dividend Coverage Ratio | 4.76 | 2.78 | 1.79 | 2.5 |
Interest Coverage Ratio
Equity Dividend Coverage Ratio
The company exhibits strong solvency, reflecting a solid long-term financial position. The debt and debt-to-equity ratios are at healthy levels, indicating a balanced capital structure. Further, the equity and debt-to-asset ratios reinforce the company's ability to manage its debts effectively. The weighted average calculation highlights the company's consistent strength in maintaining a sustainable level of debt relative to its equity and assets.
| Solvency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debt Ratio | 0.11 | 0.15 | 0.16 | 0.2 | 0.17 |
| Debt to Equity Ratio | 0.12 | 0.18 | 0.19 | 0.25 | 0.2 |
| Equity Ratio | 0.89 | 0.85 | 0.84 | 0.8 | 0.83 |
| Debt To Asset Ratio | 0.06 | 0.08 | 0.08 | 0.1 | 0.09 |
Debt Ratio
Debt to Equity Ratio
Equity Ratio
Debt To Asset Ratio
The company's liquidity position is weak, indicating potential difficulties in meeting its short-term obligations. While the current ratio is below the ideal benchmark, quick and cash ratios further highlight the company's limited liquid assets. Operating cash flow ratios suggest inconsistent cash generation from operations. The weighted average calculation underscores this concerning trend, reflecting negatively on the company's ability to manage its immediate liabilities effectively.
| Liquidity Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Current Ratio | 1.22 | 1.24 | 1.13 | 1.09 | 1.1 |
| Quick Ratio | 0.17 | 0.34 | 0.16 | 0.13 | 0.16 |
| Cash Ratio | 0.02 | 0.12 | 0.03 | 0.03 | 0.03 |
| Operating Cash Flow Ratio | -0.24 | 0.4 | -0.09 | 0.11 | 0.2 |
Current Ratio
Quick Ratio
Cash Ratio
Operating Cash Flow Ratio
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Mawana Sugars Ltd | 7.25 | 4.09 | Highly Undervalued | 105.00 | 9.39 | 37.00 |
| 2 | KCP Sugar & Industries Corporation Ltd | 6.61 | 22.42 | Overvalued | 1.00 | -0.23 | 11.00 |
| 3 | Davangere Sugar Company Ltd | 6.40 | 60.17 | Neutral | 49.00 | 0.06 | 9.00 |
| 4 | Avadh Sugar & Energy Ltd | 6.16 | 10.89 | Undervalued | 221.00 | 28.63 | 57.00 |
| 5 | Dhampur Bio Organics Ltd | 6.00 | 53.71 | Neutral | 131.00 | 3.76 | 25.00 |
| 6 | KM Sugar Mills Ltd | 5.97 | 4.67 | Undervalued | 87.00 | 5.81 | 53.00 |
| 7 | Rana Sugars Ltd | 5.92 | 8.27 | Neutral | 41.00 | 1.55 | 24.00 |
| 8 | Magadh Sugar & Energy Ltd | 5.37 | 10.05 | Neutral | 147.00 | 45.07 | 64.00 |
| 9 | Ponni Sugars (Erode) Ltd | 5.27 | 5.64 | Neutral | 36.00 | 55.86 | 48.00 |
| 10 | Sakthi Sugars Ltd | 3.51 | -1.18 | Neutral | -37.00 | 2.37 | -177.00 |
| 11 | Dwarikesh Sugar Industries Ltd | 3.51 | 26.52 | Overvalued | 87.00 | 1.66 | 31.00 |
| 12 | Kothari Sugars & Chemicals Ltd | 3.51 | 92.89 | Highly Overvalued | 28.00 | 0.80 | 2.00 |
Dhampur Bio Organics' management effectiveness is mixed. Revenue growth has been inconsistent, and profitability has declined. While promoter holding is stable, increasing debt levels raise concerns about financial leverage and capital efficiency. Recent performance indicates challenges in maintaining profitability and managing efficiency.
| Category | Metric | Value | Assessment |
|---|---|---|---|
| PROS | Promoter Holding | 50.79% | Stable promoter holding indicates consistent ownership structure. |
| CONS | Profit Growth (TTM) | -56% | Significant decline in recent profit growth. |
| Borrowings | ₹1,162 Cr | Increasing debt levels may strain financial resources. |
Financial Performance & Growth
Dhampur Bio Organics' financial performance shows fluctuations. Sales growth was strong previously but has recently slowed. The compounded sales growth for the past 3 years is 6%, but the TTM sales growth is 0%. Profit growth has declined significantly, with a 3-year compounded profit growth of -46% and a TTM profit growth of -56%. The operating profit margin (OPM) shows volatility. Declining profit margins and inconsistent sales growth raise concerns about the sustainability of financial performance.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Sales Growth (%) | 53.93% | -22.56% | -0.16% | |
| OPM (%) | 12% | 8% | 8% | 7% |
Capital Efficiency & Returns
Capital efficiency and returns for Dhampur Bio Organics are concerning. The ROCE has declined from 11% in Mar 2022 to 4% in Mar 2025, indicating decreasing efficiency in capital utilization. The cash conversion cycle is extended, with 270 days in Mar 2025, indicating inefficient working capital management. These metrics suggest that the company is struggling to generate adequate returns from its capital investments and is facing challenges in managing its working capital effectively.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| ROCE % | 11% | 10% | 5% | 4% |
| Cash Conversion Cycle (Days) | 312 | 154 | 269 | 270 |
Financial Health & Prudence
Dhampur Bio Organics shows signs of increasing financial leverage. Borrowings have risen from ₹835 Cr in Mar 2022 to ₹1,162 Cr in Mar 2025, indicating higher debt levels. The increasing reliance on borrowings could pose risks if not managed effectively. The dividend payout has increased which may not be sustainable given the decline in profits.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Borrowings (Cr) | 835 | 810 | 1,057 | 1,162 |
| Dividend Payout (%) | 0% | 21% | 36% | 56% |
Shareholding & Ownership Structure
The shareholding pattern of Dhampur Bio Organics indicates moderate stability. Promoter holding has remained relatively stable. However, FII holding has decreased from 8.55% in May 2022 to 0.54% in Mar 2025, which could indicate reduced confidence from foreign institutional investors. DII holding has remained stable. This mixed trend in shareholding suggests a need to monitor investor confidence and participation closely.
| Metric | May 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Promoter Holding (%) | 49.08% | 50.22% | 50.79% | 50.79% |
| FII Holding (%) | 8.55% | 5.34% | 1.95% | 0.54% |
| DII Holding (%) | 0.49% | 0.47% | 0.45% | 0.45% |
The risk assessment for Dhampur Bio Organics is rated 'Orange' due to segment performance volatility reflected in fluctuating sales and profit growth. The company's increasing debt levels and decreasing ROCE indicate potential financial strain.
Segment performance volatility
Dhampur Bio Organics experiences notable segment performance volatility. Quarterly sales and profit growth rates fluctuate significantly, indicating inconsistent performance across different periods. The YOY Sales Growth % has varied widely, from -52.82% to 70.73%. Similarly, YOY Profit Growth % has shown extreme variations, ranging from -39,050% to 2,367.65%.
Foreign exchange or interest rate exposure
The interest expenses of Dhampur Bio Organics is increasing. Interest expenses have risen from ₹30 Cr in Mar 2022 to ₹67 Cr in Mar 2025, indicating a growing financial burden from debt. This trend suggests that the company's profitability could be increasingly sensitive to changes in interest rates, especially with rising debt levels.
Accounting quality red flags
The analysis did not identify any specific accounting quality red flags.
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Hour Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 2 Hours Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 4 Hours Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Day Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Week Timeframe
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Month Timeframe